The PennZone

  • Home
  • Business
  • Real Estate
  • Travel
  • Health
  • Technology
  • Non-profit
  • Construction
  • Legal

Roger B. Bagwell, Ph.D., is named the Actuated Medical Director, Neural Device Operations
The PennZone/10296264

Trending...
  • Cold. Clean. Anywhere. Meet FrostSkin
  • Apostle Margelee Hylton Announces the Release of Third Day Prayer
  • Atlanta Magazine Names Dr. Rashad Richey One of Atlanta's Most Influential Leaders in 2026 as the FIFA World Cup Approaches
Actuated Medical Inc.
BELLEFONTE, Pa. - PennZone -- Actuated Medical, Inc. is pleased to announce that Roger B. Bagwell, Ph.D. is now the Actuated Medical Director, Neural Device Operations. This transition reflects the company's continued expansion in the neural device sector and Dr. Bagwell's pivotal role in advancing Actuated's cutting-edge technologies.

As Director, Neural Device Operations, Dr. Bagwell will oversee the development, optimization, and strategic direction of Actuated's neural-focused device portfolio, Actuated Neuroscience, ensuring performance excellence from concept to commercialization. He will lead engagement with brain researchers and brain computer interface (BCI) companies that are focused on improving outcomes for patients dealing with neurological conditions.

"Our team has made significant strides in helping the neural device researcher achieve better data to improve their understanding of the brain. With Roger at the helm of our neural device operations, we are confident that we will continue delivering groundbreaking solutions to enable clinical researchers to improve patient outcomes." said Maureen L. Mulvihill, Ph.D., President and CEO of Actuated Medical.

More on The PennZone
  • Off The Hook YS (NY SE: OTH) Executes Transformational Apex Acquisition, Creating Vertically Integrated Marine Powerhouse with $60M Inventory Capacity
  • Tri-State Area Entrepreneur Launches K-Chris: A Premium Digital Destination for Luxury Fragrances
  • Why One American Manufacturer Builds BBQ Smokers to Aerospace Standards
  • Diversified Roofing Solutions Strengthens Industry Leadership With Expanded Roofing Services Across South Florida
  • ZRCalc™ Cinema Card Calculator Now Available for Nikon ZR Shooters

"I am excited to take this step and transition my position to Director, Neural Device Operations. Actuated Neuroscience has an immense amount of neural technology ideas, and I look forward to leading our talented team in developing advanced solutions that enhance patient care and expand the possibilities of neural device applications." said Roger B. Bagwell, Ph.D.

Actuated Medical is committed to pushing the boundaries of medical technology through innovation and collaboration. This transition underscores the company's dedication to developing advanced solutions that extend the longevity and performance of penetrating neural implants and other neuro-focused medical devices.

About Actuated Medical, Inc.

Actuated Medical is a medical technology innovator that is pioneering motion-based solutions to address critical, unmet clinical needs in gastroenterology and neurology. With an unwavering focus on innovation, safety, and superior quality, the Actuated team is committed to delivering transformative products that empower healthcare professionals to achieve greater precision, enhance efficiency, and drive better patient outcomes while reducing healthcare costs. The company's technologies are backed by a strategic path to commercialization with multiple exit opportunities, supported by invaluable feedback from industry leaders. Actuated holds 43 issued U.S. and international patents, 8 FDA 510(k) clearances, 5 Investigational Device Exemptions (IDEs), 33 pre-submissions, and has completed or is conducting 8 clinical studies. Honored with two Small Business Administration (SBA) Tibbetts Awards for SBIR commercialization excellence (2014 & 2020), Actuated operates out of a state-of-the-art 20,000 sq. ft. facility in central Pennsylvania, certified ISO 13485 and a Woman-Owned Small Business (WOSB), reflecting its steadfast commitment to quality and innovation. actuatedmedical.com

More on The PennZone
  • Revolutionary Data Solution Transforms Health Insurance Underwriting Accuracy
  • $36 Million LOI to Acquire High Value Assets from Vivakor Inc in Oklahoma's STACK Play — Building Cash Flow and Scalable Power Infrastructure; $OLOX
  • Kobie Wins for AI Innovations in the 2026 Stevie® Awards for Sales & Customer Service
  • Author Jeff Bogle to Host Street Cats Mediterranean Cruise Featuring Cat Behaviorist Molly DeVoss
  • Berman | Sobin | Gross LLP Celebrates 35 Years of Advocating for Maryland's Injured Workers and Families

###

For media inquiries, please contact Maureen L. Mulvihill, Ph.D. by phone at 814-355-0003 or email at info@actuatedmedical.com.

Additional information can be found by visiting:

ActuatedMedical.com

GripTract.com

ActuatedNeuroscience.com

TubeClear.com

Contact
Actuated Medical, Inc.
***@actuatedmedical.com


Source: Actuated Medical, Inc.

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • How Specialized Game Development Services Are Powering the Next Wave of Interactive Entertainment
  • Brain Drain Unlimited Strengthens Legal Advocacy with Advanced Training from Villanova University
  • Don't Settle for a Lawyer Who Just Speaks Spanish. Demand One Who Understands Your Story
  • Dan Williams Promoted to Century Fasteners Corp. – General Manager, Operations
  • Ski Johnson Inks Strategic Deals with Three Major Food Chain Brands
  • NIL Club Advances Agent-Free NIL Model as Oversight Intensifies Across College Athletics
  • Pallet Company Partners with Internet Marketing Company
  • Atlanta Magazine Names Dr. Rashad Richey One of Atlanta's Most Influential Leaders in 2026 as the FIFA World Cup Approaches
  • Apostle Margelee Hylton Announces the Release of Third Day Prayer
  • Slotozilla Reports Strong Q4 Growth and Sigma Rome Success
  • "Lights Off" and Laughs On: Joseph Neibich Twists Horror Tropes in Hilariously Demonic Fashion
  • Families Gain Clarity: Postmortem Pathology Expands Private Autopsy Services in St. Louis
  • Beethoven: Music of Revolution and Triumph - Eroica
  • Don't Get Burned by High Heater Prices in Philly This Winter!
  • Amy Turner Receives 2025 ENPY Partnership Builder Award from The Community Foundation
  • Hubble Tension Solved? Study finds evidence of an 'Invisible Bias' in How We Measure the Universe
  • Boonuspart.ee Acquires Kasiino-boonus.ee to Strengthen Its Position in the Estonian iGaming Market
  • Vines of Napa Launches Partnership Program to Bolster Local Tourism and Economic Growth
  • Finland's €1.3 Billion Digital Gambling Market Faces Regulatory Tug-of-War as Player Protection Debate Intensifies
  • Angels Of Dirt Premieres on Youtube, Announces Paige Keck Helmet Sponsorship for 2026 Season

Popular on PennZone

  • Michael Judkins Releases New Poetry Book, Deeper Than You Think
  • $80 Million Revenue Backlog for AI Cybersecurity Company Building the Future of Integrated Cybersecurity and Public Safety: $CYCU
  • Still Using Ice? FrostSkin Reinvents Hydration
  • Accountants Near Me Cheyenne Opens U.S. Directory for Accountants, Bookkeepers and Tax Services
  • Precision Adult Care Expands 24/7 Adult In-Home Care Services to Meet Growing Demand in the Coachella Valley
  • Boston Industrial Solutions' Natron® 512N Series UV LED Ink Earns CPSIA Certification
  • OneVizion Announces Next Phase of Growth as Brad Kitchens Joins Board of Directors
  • 2025 Top Lawyers - ELA Awards by Expert Law Attorneys
  • The Ms. Corporate America Maryland Competition Returns for an Unforgettable Evening of Leadership, Excellence, and Empowerment
  • Jim Breuer is Coming to The Eichelberger Performing Arts Center This May

Similar on PennZone

  • Capsadyn® Launches on Amazon, Offering Non-Burning Capsaicin Pain Relief
  • Conexwest Delivers Custom Shipping Container MRI Lab, Saving California Hospital an Estimated $9 Million in Renovation Costs
  • FDA Meeting Indicates a pivotal development that could redefine the treatment landscape for suicidal depression via NRx Pharmaceuticals: $NRXP
  • $2.7 Million 2025 Revenue; All Time Record Sales Growth; 6 Profitable Quarters for Homebuilding Industry: Innovative Designs (Stock Symbol: IVDN)
  • CCHR: Decades of Warnings, Persistent Inaction; Studies Raise New Alarms on Psychiatric Drug Safety
  • Arbutus Medical Raises C$9.3M to Accelerate Growth of Surgical Workflow Solutions Outside the OR
  • Families Gain Clarity: Postmortem Pathology Expands Private Autopsy Services in St. Louis
  • High-Margin Energy & Digital Infrastructure Platform Created after Merger with Established BlockFuel Energy, Innovation Beverage Group (NAS DAQ: IBG)
  • Diveroli Investment Group Files 13D in PetMed Express, Highlights Strategic Value, Asset Floor, and Multiple Takeover Pathways
  • VC Fast Pitch Is Coming to Maryland on March 26th
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us